Adjuvant chemotherapy for non-small-cell lung cancer--the smoke clears.

Suppr

超能文献

作者信息

Pisters Katherine M W

出版信息

N Engl J Med. 2005 Jun 23;352(25):2640-2. doi: 10.1056/NEJMe058110.

DOI:10.1056/NEJMe058110

PMID:15972872

Abstract

摘要

相似文献

Adjuvant chemotherapy for non-small-cell lung cancer--the smoke clears.

N Engl J Med. 2005 Jun 23;352(25):2640-2. doi: 10.1056/NEJMe058110.

Adjuvant chemotherapy in resected non-small cell lung cancer.

Rays. 2004 Oct-Dec;29(4):435-7.

Early-stage lung cancer findings end a debate, put focus on next steps.

J Natl Cancer Inst. 2004 Jul 21;96(14):1054-5. doi: 10.1093/jnci/96.14.1054.

Missing patient-reported outcome data in an adjuvant lung cancer study.

J Clin Oncol. 2008 Nov 1;26(31):5018-9. doi: 10.1200/JCO.2008.18.2154. Epub 2008 Sep 22.

[Postoperative adjuvant chemotherapy for non-small cell lung cancer].

Gan To Kagaku Ryoho. 2005 Jun;32(6):765-9.

[Adjuvant chemotherapy for non-small cell lung cancer].

Gan To Kagaku Ryoho. 2006 Dec;33(13):1985-90.

[Vinorelbine for non-small cell lung cancer].

Nihon Rinsho. 2002 May;60 Suppl 5:353-8.

Non-small-cell lung cancer mRNA expression signature predicting response to adjuvant chemotherapy.

J Clin Oncol. 2010 Oct 10;28(29):4404-7. doi: 10.1200/JCO.2010.31.0144. Epub 2010 Sep 7.

Can adjuvant chemotherapy improve survival in patients with early-stage, resected non-small-cell lung cancer?

Nat Clin Pract Oncol. 2005 Nov;2(11):552-3. doi: 10.1038/ncponc0350.

Adjuvant chemotherapy for lung cancer--a new standard of care.

N Engl J Med. 2004 Jan 22;350(4):404-5. doi: 10.1056/NEJMe038211.

引用本文的文献

Clinical features and prognosis according to genomic mutations in primary and metastatic lesions of non-small-cell lung cancer.

Thorac Cancer. 2022 Jun;13(11):1642-1650. doi: 10.1111/1759-7714.14432. Epub 2022 Apr 24.

Pembrolizumab plus allogeneic NK cells in advanced non-small cell lung cancer patients.

J Clin Invest. 2020 May 1;130(5):2560-2569. doi: 10.1172/JCI132712.

An important discovery on combination of irreversible electroporation and allogeneic natural killer cell immunotherapy for unresectable pancreatic cancer.

Oncotarget. 2017 Oct 19;8(60):101795-101807. doi: 10.18632/oncotarget.21974. eCollection 2017 Nov 24.

Using circulating tumor cells to evaluate the efficacy of irreversible electroporation for unresectasble pancreatic cancer.

Immunol Res. 2018 Feb;66(1):172-178. doi: 10.1007/s12026-017-8959-2.

Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.

J Cancer Res Clin Oncol. 2017 Dec;143(12):2607-2618. doi: 10.1007/s00432-017-2513-4. Epub 2017 Sep 4.

Clinical efficacy of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced non-small cell lung cancer.

Immunol Res. 2017 Aug;65(4):880-887. doi: 10.1007/s12026-017-8927-x.

Adjuvant cellular immunotherapy in patients with resected primary non-small cell lung cancer.

Oncoimmunology. 2015 May 27;4(9):e1038017. doi: 10.1080/2162402X.2015.1038017. eCollection 2015 Sep.

Effects of a gemcitabine plus platinum regimen combined with a dendritic cell-cytokine induced killer immunotherapy on recurrence and survival rate of non-small cell lung cancer patients.

Exp Ther Med. 2014 May;7(5):1403-1407. doi: 10.3892/etm.2014.1574. Epub 2014 Feb 21.

Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: results from a randomized trial, JBR.10.

J Clin Oncol. 2008 Nov 1;26(31):5052-9. doi: 10.1200/JCO.2007.12.6094. Epub 2008 Sep 22.

Survival after surgery in stage IA and IB non-small cell lung cancer.

Am J Respir Crit Care Med. 2008 Mar 1;177(5):516-23. doi: 10.1164/rccm.200706-815OC. Epub 2007 Nov 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验